Overcoming IGF1R-mediated resistance to oncolytic HSV1 and radiotherapy via triple combination therapy.
- DOI
- 10.1038/s41419-026-09090-5
- Published
- 2026 Jul 17
- Container
- Cell death & disease
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41419-026-09090-5,
title = {Overcoming IGF1R-mediated resistance to oncolytic HSV1 and radiotherapy via triple combination therapy.},
author = {Miller AA and Noh MH and Kang JM and Kim J and Nguyen L and Kouaho AS and Nguyen G and Huang M and Bean SM and Davis J and Mullarkey MP and Krishnan S and Zhao Z and Chiocca EA and Lee TJ and Yoo JY},
year = {2026},
journal = {Cell death \& disease},
doi = {10.1038/s41419-026-09090-5},
url = {https://doi.org/10.1038/s41419-026-09090-5}
}RIS
TY - JOUR TI - Overcoming IGF1R-mediated resistance to oncolytic HSV1 and radiotherapy via triple combination therapy. AU - Miller AA AU - Noh MH AU - Kang JM AU - Kim J AU - Nguyen L AU - Kouaho AS AU - Nguyen G AU - Huang M AU - Bean SM AU - Davis J AU - Mullarkey MP AU - Krishnan S AU - Zhao Z AU - Chiocca EA AU - Lee TJ AU - Yoo JY PY - 2026 JO - Cell death & disease DO - 10.1038/s41419-026-09090-5 UR - https://doi.org/10.1038/s41419-026-09090-5 ER -
APA
AA, M., MH, N., JM, K., J, K., L, N., AS, K., G, N., M, H., SM, B., J, D., MP, M., S, K., Z, Z., EA, C., TJ, L., & JY, Y. (2026). Overcoming IGF1R-mediated resistance to oncolytic HSV1 and radiotherapy via triple combination therapy.. Cell death & disease. https://doi.org/10.1038/s41419-026-09090-5
Source records
- pubmed · retrieved 2026-09-26T14:37:15.388Z